Description

3β-[(3-O,4-o-Dimethyl-6-Deoxy-β-D-Glucopyranosyl)Oxy]-5,14,19-Trihydroxy-5β-Card-20(22)-Enolide is a high-purity cardiac glycoside derivative, a critical intermediate in advanced pharmaceutical synthesis. This compound matters for its role as a key building block in the research and development of novel cardioactive agents and other specialized therapeutic molecules. It is primarily needed by pharmaceutical R&D laboratories, biotechnology companies, and fine chemical manufacturers focused on producing high-value active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of novel cardiac glycosides and other steroidal drugs.
• Biochemical Research: Used as a reference standard or investigational compound in studies of sodium-potassium ATPase inhibition and cardiac cell function.
• API Development: A key starting material for the development and scale-up of new Active Pharmaceutical Ingredients (APIs) with targeted biological activity.
• Academic Research: Employed in university and institutional laboratories for pharmacological and medicinal chemistry research projects.
• Process Chemistry: Utilized in route scouting and optimization for the efficient industrial-scale production of complex therapeutic molecules.

Basic Information

Product Name	3β-[(3-O,4-o-Dimethyl-6-Deoxy-β-D-Glucopyranosyl)Oxy]-5,14,19-Trihydroxy-5β-Card-20(22)-Enolide
CAS No.	34900-73-7
Molecular Formula	C30H46O10
Molecular Weight	566.68 g/mol
Synonyms	3β-[(3-O,4-o-Dimethyl-6-deoxy-β-D-glucopyranosyl)oxy]-5,14,19-trihydroxy-5β-card-20(22)-enolide; 3β-[(3-O,4-o-Dimethyl-6-deoxy-β-D-glucopyranosyl)oxy]-5,14,19-trihydroxy-5β,14β-card-20(22)-enolide; 3β-[(3-O,4-o-Dimethyl-6-deoxy-β-D-glucopyranosyl)oxy]-5,14,19-trihydroxy-card-20(22)-enolide; Desglucouzarin; Uzarigenin 3β-O-β-D-digitaloside; 16-Formylgitoxigenin 3-O-β-D-digitaloside; Strophanthidin 3-O-β-D-digitaloside (related derivative).
EINECS	Contact for details

Quality Control

Our 3β-[(3-O,4-o-Dimethyl-6-Deoxy-β-D-Glucopyranosyl)Oxy]-5,14,19-Trihydroxy-5β-Card-20(22)-Enolide is produced under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical intermediates. Certificates of Analysis (COA) detailing purity (typically ≥95% by HPLC), identification, and impurity profiles are available upon request. We support compliance with cGMP and ICH Q7 guidelines where applicable.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound may be hygroscopic (moisture-sensitive); ensure the container is sealed under an inert atmosphere if specified. Keep away from strong acids and oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.